300 antibody hits in as few as 3 months?

Distributed Bio’s SuperHuman antibody screening library makes it possible with unparalleled diversity, superior developability, and speed. 100 times more diverse than any previously generated, the platform enables a greater number of hits with cross-species coverage, and improved developability profiles with respect to thermostability, aggregation potential, and immunogenicity using scaffolds based on prior Phase 1 success.

In this webinar, you’ll learn how the SuperHuman platform not only rapidly delivers a high volume of hits but can optimize the antibodies identified through more conventional means.


  • Jacob Glanville, PhD, Co-Founder and Chief Scientific Officer, Distributed Bio